Reciprocal transactivation between HIV-1 and other human viruses

Virology

Volumn 352, Issue 1, 2006, Pages 1-13

  White, Martyn K ^a   Gorrill, Timothy S ^a   Khalili, Kamel ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV 1; Promoters; Tat; Transactivation

Indexed keywords

TRANSACTIVATOR PROTEIN; VIRUS PROTEIN; VPR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADENOVIRUS; ANTIGEN PRESENTATION; APOPTOSIS; BK VIRUS; CELL TYPE; CYTOKINE RELEASE; CYTOMEGALOVIRUS; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; GENETIC TRANSCRIPTION; HERPES SIMPLEX VIRUS 1; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE DEFICIENCY; JC VIRUS; KAPOSI SARCOMA; LIFE CYCLE; MOLECULAR INTERACTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; TRANSACTIVATION; TRANSCRIPTION INITIATION; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSCRIPTION; VIRUS VIRULENCE;

GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAT; HIV-1; HUMANS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; VIRAL PROTEINS; VIRUS DISEASES; VIRUSES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33746750048     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.04.006     Document Type: Short Survey

References (194)

1. Aaron L., Saadoun D., Calatroni I., Launay O., Memain N., Vincent V., Dupont G., Bouchaud B., Valeyre O., and Lortholary D. Tuberculosis in HIV-infected patients: a comprehensive review. Clin. Microbiol. Infect. 10 (2004) 388-398
2. Abraham S., Sawaya B.E., Safak M., Batuman O., Khalili K., and Amini S. Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells. Virology 309 (2003) 196-202
3. Abraham S., Sweet T., Sawaya B.E., Rappaport J., Khalili K., and Amini S. Cooperative interaction of C/EBP beta and Tat modulates MCP-1 gene transcription in astrocytes. J. Neuroimmunol. 160 (2005) 219-227
4. Agostini I., Navarro J.M., Rey F., Bouhamdan M., Spire B., Vigne R., and Sire J. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB. J. Mol. Biol. 261 (1996) 599-606
5. Albini A., Barillari G., Benelli R., Gallo R.C., and Ensoli B. Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 4838-4842
6. Ambinder R.F. Epstein-Barr virus associated lymphoproliferations in the AIDS setting. Eur. J. Cancer 37 (2001) 1209-1216
7. Ambrosino C., Ruocco M.R., Chen X., Mallardo M., Baudi F., Trematerra S., Quinto I., Venuta S., and Scala G. HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors. J. Biol. Chem. 272 (1997) 14883-14892
8. Amini S., Khalili K., and Sawaya B.E. Effect of HIV-1 Vpr on cell cycle regulators. DNA Cell Biol. 23 (2004) 249-260
9. Anders H.J., and Goebel F.D. Cytomegalovirus polyradiculopathy in patients with AIDS. Clin. Infect. Dis. 27 (1998) 345-352
10. Armstrong W., Calabrese L., and Taege A.J. HIV update 2005: origins, issues, prospects, and complications. Clevel. Clin. J. Med. 72 (2005) 73-78
11. Baer R., Bankier A.T., Biggin M.D., Deininger P.L., Farrell P.J., Gibson T.J., Hatfull G., Hudson G.S., Satchwell S.C., and Seguin C. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310 (1984) 207-211
12. Balthazar E.J., Megibow A.J., Fazzini E., Opulencia J.F., and Engel I. Cytomegalovirus colitis in AIDS: radiographic findings in patients. Radiology 155 (1985) 585-595
13. Barillari G., and Ensoli B. Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma. Clin. Microbiol. Rev. 15 (2002) 310-326
14. Barillari G., Gendelman R., Gallo R.C., and Ensoli B. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 7941-7945
15. Beilke M.A., Japa S., and Vinson D.G. HTLV-I and HTLV-II virus expression increase with HIV-1 coinfection. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 17 (1998) 391-397
16. Berger J.R. Progressive multifocal leukoencephalopathy in acquired immuno-deficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions. J. NeuroVirol. 9 Suppl. 1 (2003) 38-41
17. Berger J.R., Chauhan A., Galey D., and Nath A. Epidemiological evidence and molecular basis of interactions between HIV and JC virus. J. NeuroVirol. 7 (2001) 3329-3338
18. Bergonzini V., Delbue S., Wang J.Y., Reiss K., Prisco M., Amini S., Khalili K., and Peruzzi F. HIV-Tat promotes cellular proliferation and inhibits NGF-induced differentiation through mechanisms involving Id1 regulation. Oncogene 23 (2004) 7701-7711
19. Biswas D.K., Salas T.R., Wang F., Ahlers C.M., Dezube B.J., and Pardee A.B. A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter. J. Virol. 69 (1995) 7437-7444
20. Bohnlein E., Siekevitz M., Ballard D.W., Lowenthal J.W., Rimsky L., Bogerd H., Hoffman J., Wano Y., Franza B.R., and Greene W.C. Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins. J. Virol. 63 (1989) 1578-1586
21. Bratt G., Hammarin A.L., Grandien M., Hedquist B.G., Nennosmo I., Sundelin B., and Seregard S. BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS 13 (1999) 1071-1075
22. Bryan B.A., Dyson O.F., McCubrey J.A., and Akula S.M. Biology of Kaposi's sarcoma-associated herpesvirus. Front. Biosci. 10 (2005) 2882-2891
23. Buonaguro L., Barillari G., Chang H.K., Bohan C.A., Kao V., Morgan R., Gallo R.C., and Ensoli B. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J. Virol. 66 (1992) 7159-7167
24. Buonaguro L., Buonaguro F.M., Giraldo G., and Ensoli B. The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J. Virol. 68 (1994) 2677-2682
25. Cantaluppi V., Biancone L., Boccellino M., Doublier S., Beneli R., Carlone S., Abini A., and Camussi G. HIV type Tat protein is a survival factor for Kaposi's sarcoma and endothelial cells. AIDS Res. Hum. Retroviruses 17 (2001) 965-976
26. Caserta M.T., and Hall C.B. A practitioner's guide to human herpesvirus-6 (HHV-6) and human herpesvirus-7 (HHV-7). AIDS Patient Care STDs 12 (1998) 833-842
27. Caserta M.T., Mock D.J., and Dewhurst S. Human herpesvirus 6. Clin. Infect. Dis. 33 (2001) 829-833
28. Cesarman E., Nador R.G., Bai F., bohenzky R.A., Russo J.J., Moore P.S., Chang P.S., Chang Y., and Knowles D.M. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J. Virol. 70 (1996) 8218-8223
29. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., and Moore P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266 (1994) 1865-1869
30. Chang Y., Moore P.S., Talbot S.J., Boshoff C.H., Zarkowska T., Paterson H., Weiss R.A., and Mittnacht S. Cyclin encoded by KS herpesvirus. Nature 382 (1996) 410
31. Chapman C.J., Harris J.D., Collins M.K., and Latchman D.S. A recombinant HIV provirus is synergistically activated by the HIV Tat protein and the HSV IE1 protein but not by the HSV IE3 protein. AIDS 5 (1991) 945-950
32. Chauhan A., Turchan J., Pocernich C., Bruce-Keller A., Roth S., Butterfield D.A., Major E.O., and Nath A. Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J. Biol. Chem. 278 (2003) 13512-13519
33. Chen G., and Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 31 296 (2002) 1634-1635
34. Cheng H., Tarnok J., and Parks W.P. Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat. J. Virol. 72 (1998) 6911-6916
35. Cheung T.W. AIDS-related cancer in the era of highly active antiretroviral therapy (HAART): a model of the interplay of the immune system, virus, and cancer. "On the offensive-The Trojan Horse is being destroyed"-Part A: Kaposi's sarcoma. Cancer Invest. 22 (2004) 774-786
36. Chowdhury M., Taylor J.P., Tada H., Rappaport J., Wong-Staal F., Amini S., and Khalili K. Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein. Oncogene 5 (1990) 1737-1742
37. Chowdhury M., Taylor J.P., Chang C.F., Rappaport J., and Khalili K. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. J. Virol. 66 (1992) 7355-7361
38. Chowdhury M., Kundu M., and Khalili K. GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system. Oncogene 8 (1993) 887-892
39. Chretien F., Belec L., Hilton D.A., Flament-Saillour M., Guillon F., Wingertsmann L., Baudrimont M., de Truchis P., Keohane C., Vital C., Love S., and Gray F. Herpes simplex virus type 1 encephalitis in acquired immunodeficiency syndrome. Neuropathol. Appl. Neurobiol. 22 (1996) 394-404
40. Cohen J. Therapies. Raising the limits. Science 296 (2002) 2322
41. Cohen E.A., Terwilliger E.F., Jalinoos Y., Proulx J., Sodroski J.G., and Haseltine W.A. Identification of HIV-1 vpr product and function. J. Acquired Immune Defic. Syndr. 3 (1990) 11-18
42. Contreras X., Bennasser Y., and Bahraoui E. IL-10 production induced by HIV-1 Tat stimulation of human monocytes is dependent on the activation of PKC beta(II) and delta isozymes. Microbes Infect. 6 (2004) 1182-1190
43. Contreras X., Bennasser Y., Chazal N., Moreau M., Leclerc C., Tkaczuk J., and Bahraoui E. Human immunodeficiency virus type 1 Tat protein induces an intracellular calcium increase in human monocytes that requires DHP receptors: involvement in TNF-alpha production. Virology 332 (2005) 316-328
44. Cubukcu-Dimopulo O., Greco A., Kumar A., Karluk D., Mittal K., and Jagirdar J. BK virus infection in AIDS. Am. J. Surg. Pathol. 24 (2000) 145-149
45. Cupp C., Taylor J.P., Khalili K., and Amini S. Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene 8 (1993) 2231-2236
46. Dal Monte P., Landini M.P., Sinclair J., Virelizier J.L., and Michelson S. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2. AIDS 11 (1997) 297-303
47. Daniel D.C., Wortman M.J., Schiller R.J., Liu H., Gan L., Mellen J.S., Chang C.F., Gallia G.L., Rappaport J., Khalili K., and Johnson E.M. Coordinate effects of human immunodeficiency virus type 1 protein Tat and cellular protein Puralpha on DNA replication initiated at the JC virus origin. J. Gen. Virol. 82 (2001) 1543-1553
48. Daniel D.C., Kinoshita Y., Khan M.A., Del Valle L., Khalili K., Rappaport J., and Johnson E.M. Internalization of exogenous human immunodeficiency virus-1 protein, Tat, by KG-1 oligodendroglioma cells followed by stimulation of DNA replication initiated at the JC virus origin. DNA Cell Biol. 23 (2004) 858-867
49. Darbinian N., Sawaya B.E., Khalili K., Jaffe N., Wortman B., Giordano A., and Amini S. Functional interaction between cyclin T1/cdk9 and Puralpha determines the level of TNFalpha promoter activation by Tat in glial cells. J. Neuroimmunol. 121 (2001) 3-11
50. D'Aversa T.G., Yu K.O., and Berman J.W. Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat. J. NeuroVirol. 10 (2004) 86-97
51. Davis G.D., Kenney S.C., Kamine J., Pagano J.S., and Huang E. Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 8642-8646
52. De Rossi A., Saggioro D., Calabro M.L., Cenzato R., and Chieco-Bianchi L. Reciprocal activation of human T-lymphotropic viruses in HTLV-I-transformed cells superinfected with HIV-1. J. Acquired Immune Defic. Syndr. 4 (1991) 380-385
53. Del Valle L., and Piña-Oviedo S. HIV disorders of the brain: pathology and pathogenesis. Front. Biosci. 11 (2006) 718-732
54. Del Valle L., Croul S., Morgello S., Amini S., Rappaport J., and Khalili K. Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukioencephalopathy. J. NeuroVirol. 6 (2000) 221-228
55. Deregibus M.C., Cantaluppi V., Doublier S., Brizzi M.F., Deambrosis I., Albini A., and Camussi G. HIV-1 Tat protein activates phosphatidylinositol 3-kinase/AKT-dependent survival pathways in Kaposi's sarcoma cells. J. Biol. Chem. 277 (2002) 25195-25202
56. Desjeux P., and Alvar J. Leishmania/HIV co-infections: epidemiology in Europe. Ann. Trop. Med. Parasitol. 97 S1 (2003) 3-15
57. Di Luca D., Secchiero P., Bovenzi P., Rotola A., Caputo A., Monini P., and Cassai E. Reciprocal in vitro interactions between human herpesvirus-6 and HIV-1 Tat. AIDS 5 (1991) 1095-1098
58. Dockrell D.H. Human herpesvirus 6: molecular biology and clinical features. J. Med. Microbiol. 52 (2003) 5-18
59. Dockrell D.H., Smith T.F., and Paya C.V. Human herpesvirus 6. Mayo Clin. Proc. 74 (1999) 163-170
60. Enam S., Sweet T.M., Amini S., Khalili K., and Del Valle L. Evidence for involvement of transforming growth factor beta1 signaling pathway in activation of JC virus in human immunodeficiency virus 1-associated progressive multifocal leukoencephalopathy. Arch. Pathol. Lab. Med. 128 (2004) 282-291
61. Ensoli B., and Sirianni M.C. Kaposi's sarcoma pathogenesis: a link between immunology and tumor biology. Crit. Rev. Oncog. 9 (1998) 107-124
62. Ensoli B., Lusso P., Schachter F., Josephs S.F., Rappaport J., Gallo R.C., and Wong-Staal F. Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. EMBO J. 8 (1989) 3019-3027
63. Ensoli B., Barillari G., Salahuddin S.Z., Gallo R.C., and Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345 (1990) 84-86
64. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R.A., Wingfield P., and Gallo R.C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67 (1993) 277-287
65. Ensoli B., Gendelman R., Markham P., Fiorelli V., Colombini S., Raffeld M., Cafaro A., Chang H.K., Brady J.N., and Gallo R.C. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371 (1994) 674-680
66. Ensoli B., Sgadari C., Barillari G., Sirianni M.C., Sturzl M., and Monini P. Biology of Kaposi's sarcoma. Eur. J. Cancer 37 (2001) 1251-1269
67. Fiorelli V., Gendelman R., Samaniego F., Markham P.D., and Ensoli B. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J. Clin. Invest. 95 (1995) 1723-1734
68. Frankel A.D., and Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55 (1988) 1189-1193
69. Frankel A.D., and Young J.A. HIV-1: fifteen proteins and an RNA. Ann. Rev. Biochem. 67 (1998) 1-25
70. Gallo R.C. The enigmas of Kaposi's sarcoma. Science 282 (1998) 1837-1839
71. Gallo R.C. Some aspects of the pathogenesis of HIV-1-associated Kaposi's sarcoma. J. Natl. Cancer Inst. Monog. 23 (1998) 55-57
72. Ganju R.K., Munshi N., Nair B.C., Liu Z.Y., Gill P., and Groopman J.E. Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells. J. Virol. 72 (1998) 6131-6137
73. Garavelli P.L., and Boldorini R. BK virus encephalitis in an HIV-seropositive patient. Recent Prog. Med. 93 (2002) 247
74. Garzino-Demo A., and Gallo R.C. HIV receptors on lymphocytes. Curr. Opin. Hematol. 10 (2003) 279-283
75. Garzino-Demo A., Chen M., Lusso P., Berneman Z., and DiPaolo J.A. Enhancement of Tat-induced transactivation of the HIV-1 LTR by two genomic fragments of HHV-6. J. Med. Virol. 50 (1996) 20-24
76. Gavioli R., Gallerani E., Fortini C., Fabris M., Bottoni A., Cannella A., Bonaccorsi A., Marastoni M., Micheletti F., Cafaro A., Rimessi R., Caputo A., and Ensoli B. HIV-1 tat protein modulated the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity. J. Immunol. 173 (2004) 3838-3843
77. Geddes M., Franceschi S., Barchielli A., Falcini F., Carli S., Cocconi G., Conti E., Crosignani P., Gafa L., Giarelli L., et al. Kaposi's sarcoma in Italy before and after the AIDS epidemic. Br. J. Cancer 69 (1994) 333-336
78. Gendelman H.E., Phelps W., Feigenbaum L., Ostrove J.M., Adachi A., Howley P.M., Khoury G., Ginsberg H.S., and Martin M.A. Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc. Natl. Acad. Sci. 83 (1986) 9759-9763
79. Giacca M. The HIV-1 Tat protein: a multifaceted target for novel therapeutic opportunities. Curr. Drug Targets Immune Endocr. Metabol. Disord. 4 (2004) 277-285
80. Glass W.G., Rosenberg H.F., and Murphy P.M. Chemokine regulation of inflammation during acute viral infection. Curr. Opin. Allergy Clin. Immunol. 3 (2003) 467-473
81. Gluck T.A., Knowles W.A., Johnson M.A., Brook M.G., and Pillay D. BK virus-associated hemorrhagic cystitis in an HIV-infected man. AIDS 8 (1994) 391-392
82. Good L., and Sun S.C. Persistent activation of NF-kappa B/Rel by human T-cell leukemia virus type 1 tax involves degradation of I kappa B beta. J. Virol. 70 (1996) 2730-2735
83. Gordon J., and Khalili K. The human polyomavirus, JCV, and neurological diseases (review). Int. J. Mol. Med. 1 (1998) 647-655
84. Gorrill T.S., and Khalili K. Cooperative interaction of p65 and C/EBPbeta modulates transcription of BKV early promoter. Virology 335 (2005) 1-9
85. Gorrill, T.S., Feliciano, M., Mukerjee, R., Sawaya, B.E., Khalili, K., White, M.K., in press. Activation of the human polyomavirus, BKV, early gene transcription by HIV-1 Tat. J. Gen. Virol.
86. Gravel A., Tomoiu A., Cloutier N., Gosselin J., and Flamand L. Characterization of the immediate-early 2 protein of human herpesvirus 6, a promiscuous transcriptional activator. Virology 308 (2003) 340-353
87. Gruffat H., Sergeant A., and Manet E. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma. Microb. Infect. 2 (2000) 671-680
88. Gulow K., Kaminski M., Darvas K., Suss D., Li-Weber M., and Krammer P.H. HIV-1 trans-activator of transcription substitutes for oxidative signaling in activation-induced T cell death. J. Immunol. 174 (2005) 5249-6520
89. Hammarskjold M.J., and Simurda M.C. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity. J. Virol. 66 (1992) 6496-6501
90. Hedquist B.G., Bratt G., Hammarin A.L., Grandien M., Nennesmo I., Sundelin B., and Seregard S. Identification of BK virus in a patient with acquired immune deficiency syndrome and bilateral atypical retinitis. Ophthamology 106 (1999) 129-132
91. Ho W.Z., Harouse J.M., Rando R.F., Gonczol E., Srinivasan A., and Plotkin S.A. Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1. J. Gen. Vir. 71 (1990) 97-103
92. Ho W.Z., Ayyavoo V., Srinivasan A., Stinski M.F., Plotkin S.A., and Gonczol E. Human immunodeficiency virus type 1 tat gene enhances human cytomegalovirus gene expression and viral replication. AIDS Res. Hum. Retrovir. 7 (1991) 689-695
93. Horvat R.T., Wood C., and Balachandran N. Transactivation of the human immunodeficiency virus promoter by human herpesvirus 6. J. Virol. 63 (1989) 970-973
94. Huang L.M., Chao M.F., Chen M.Y., Shih H., Chiang Y.P., Chuang C.Y., and Lee C.Y. Reciprocal regulatory interaction between human herpesvirus 8 and human immunodeficiency virus type 1. J. Biol. Chem. 276 (2001) 13427-13432
95. Inoue Y., Yasukawa M., and Fujita S. Induction of T-cell apoptosis by human herpesvirus 6. J. Virol. 71 (1997) 3751-3759
96. Itin P.H., and Lautenschlager S. Viral lesions of the mouth in HIV-infected patients. Dermatology 194 (1997) 1-7
97. Jeang K., Xiao H., and Rich E.A. Multifacteted activities of the HIV-1 transactivator of transcription. Tat. J.B.C. 274 (1999) 28837-28840
98. Johnson E.M. The Pur protein family: clues to function from recent studies on cancer and AIDS. Anticancer Res. 23 (2003) 2093-2100
99. Karn J. Tackling Tat. J. Mol. Biol. 293 (1999) 235-254
100. Kashanchi F., Thompson J., Sadaie M.R., Doniger J., Duvall J., Brady J.N., and Rosenthal L.J. Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus-6. Virology 201 (1994) 95-106
101. Kelly G.D., Ensoli B., Gunthel C.J., and Offerman M.K. Purified Tat induces inflammatory response genes in Kaposi's sarcoma cells. AIDS 12 (1998) 1753-1761
102. Kenny S., Kamine J., Markovitz D., Fenrick R., and Pagano J. An Epstein-Barr virus immediate-early gene product transactivates gene expression from the human immunodeficiency virus long terminal repeat. Proc. Natl. Acad. Sci. 85 (1988) 1652-1656
103. Khalili K., Gordon J., and White M.K. The polyomavirus, JCV, and its involvement in human disease. In: Ahsan N. (Ed). Polyomaviruses and Human Diseases (2004), Landes Bioscience, Georgetown, TX
104. Kim B.O., Liu Y., Zhou B.Y., and He J.J. Induction of C chemokine XCL1 (lymphotactin/single C motif-1 alpha/activation-induced, T cell-derived and chemokine-related cytokine) expression by HIV-1 Tat protein. J. Immunol. 172 (2004) 1888-1895
105. Kino T., and Pavlakis G.N. Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1. DNA Cell Biol. 23 (2004) 193-205
106. Kino T., Gragerov A., Slobodskaya O., Tsopanomichalou M., Chrousos G.P., and Pavlakis G.N. Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators. J. Virol. 76 (2002) 3974-9724
107. Knowles D.M. Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma. Hematol./Oncol. Clin. North Am. 10 (1996) 1081-1089
108. Knowles W.A., Pillay D., Johnson M.A., Hand J.F., and Brown D.W. Prevalence of long-term BK and JC excretion in HIV-infected adults and lack of correlation with serological markers. J. Med. Virol. 59 (1999) 474-479
109. Knox K.K., and Carrigan D.R. Active HHV-6 infection in the lymph nodes of HIV-infected patients: in vitro evidence that HHV-6 can break HIV latency. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 11 (1996) 370-378
110. Krachmarov C.P., Chepenik L.G., Barr-Vagell S., Khalili K., and Johnson E.M. Activation of the JC virus Tat-responsive transcriptional control element by association of the Tat protein of human immunodeficiency virus 1 with cellular protein Pur alpha. Proc. Natl. Acad. Sci. U.S.A. 93 (1997) 12117-14112
111. Kumar P.P., Purbey P.K., Ravi D.S., Mitra D., and Galande S. Displacement of SATB1-bound histone deacetylase 1 corepressor by the human immunodeficiency virus type 1 transactivator induces expression of interleukin-2 and its receptor in T cells. Mol. Cell. Biol. 25 (2005) 1620-1633
112. Laguna F., Garcia-Samaniego J., Alonso M.J., Alzarez I., and Gonzalez-Lahoz J.M. Pseudotumoral appearance of cytomegalovirus esophagitis and gastritis in AIDS patients. Am. J. Gastroenterol. 88 (1993) 1108-1111
113. Laspia M.F., Rice A.P., and Mathews M.B. Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation. Genes Dev. 4 (1990) 2397-2408
114. Lautenschlager I., Linnavuori K., Lappalainen M., Suni J., and Hockerstedt K. HHV-6 reactivation is often associated with CMV infection in liver transplant recipients. Transplant Int. 13 S1 (2000) 351-353
115. Lazzarotto T., Furlini G., Re M.C., Ramazzotti E., Campisi B., and Landini M.P. Human cytomegalovirus replication correlates with differentiation in a hematopoietic progenitor cell line and can be modulated by HIV-1. Arch. Virol. 135 (1994) 13-28
116. Li L., Li H.S., Pauza C.D., Bukrinsky M., and Zhao R.Y. Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions. Cell Res. 15 (2005) 923-934
117. List A.F., Greco F.A., and Vogler L.B. Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus. J. Clin. Oncol. 5 (1987) 1673-1689
118. Lusso P., and Gallo R.C. Human herpesvirus 6 in AIDS. Immunol. Today 16 (1995) 67-71
119. Lusso P., Ensoli B., Markham P.D., Ablashi D.V., Salahuddin S.Z., Tschachler E., Wong-Staal F., and Gallo R.C. Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature 337 (1989) 370-373
120. MacMahon E.M., Glass J.D., Hayward S.D., Mann R.B., Charache P., McArthur J.C., and Ambinder R.F. Association of Epstein-Barr virus with primary central nervous system lymphoma in AIDS. AIDS Res. Hum. Retroviruses 8 (1992) 740-742
121. Mallon R., Borkowski J., Albin R., Pepitoni S., Schwartz J., and Kieff E. The Epstein-Barr virus BZLF1 gene product activates the human immunodeficiency virus type 1 5′ long terminal repeat. J. Virol. 64 (1990) 6282-6285
122. Margalith M., Medina D.J., Hsiung G.D., Smith B.R., D' Aquila R.T., Kaplan J.C., Bechtel L., Wang M.Z., Skolnik P.R., and Hirsch M.S. Interactions between HIV-1 and cytomegalovirus in human osteosarcoma cells carrying both viruses. AIDS Res. Hum. Retroviruses 9 (1993) 519-527
123. Markowitz R.B., Thompson H.C., Mueller J.F., Cohen J.A., and Dynan W.S. Incidence of BK and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. J. Infect. Dis. 167 (1993) 13-20
124. Merat R., Amara A., Lebbe C., de The H., Morel P., and Saib A. HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi sarcoma-associated herpesvirus (KSHV) reactivation. Int. J. Cancer 97 (2002) 791-795
125. Mischitelli M., Fioriti D., Videtta M., Degener A.M., Antinori A., Cinque P., Giordano A., and Pietropaolo V. Investigation on the role of cell transcriptional factor Sp1 and HIV-1 TAT protein in PML onset or development. J. Cell Physiol. 204 (2005) 913-918
126. Moore P.S., Boshoff C., Weiss R.A., and Chang Y. Molecular mimicry of human cytokine and cytokine genes by KSHV. Science 274 (1996) 1739-1744
127. Morini M., Benelli R., Giunciuglio D., Carlone S., Arena G., Noonan D.M., and Albini A. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology. Biochem. Biophys. Res. Commun. 273 (2000) 267-271
128. Moriuchi H., and Moriuchi M. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I. Virology 278 (2000) 514-519
129. Moriuchi M., Moriuchi H., and Fauci A.S. HTLV type I Tax activation of the CXCR4 promoter by association with nuclear respiratory factor 1. AIDS Res. Hum. Retroviruses 15 (1999) 821-827
130. Murphy P.M. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat. Immunol. 2 (2001) 116-122
131. Nabel G.J., Rice S.A., Knipe D.M., and Baltimore D. Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells. Science 239 (1988) 1299-1302
132. Nebuloni M., Tosoni A., Bodorini R., Monga G., Carsana L., Bonetto S., Abeli C., Caldarelli R., Vago L., and Costanzi G. BK virus renal infection in a patient with acquired immunodeficiency syndrome. Arch. Pathol. Lab. Med. 123 (1999) 807-811
133. Nicot C. Current views in HTLV-I-associated adult T-cell leukemia/lymphoma. Am. J. Hematol. 78 (2005) 232-239
134. Orem J., Otieno M.W., and Remick S.C. AIDS-associated cancer in developing nations. Curr. Opin. Oncol. 16 (2004) 468-476
135. Ostrove J.M., Leonard J., Weck K.E., Rabson A.B., and Gendelman H.E. Activation of the human immunodeficiency virus by herpes simplex virus type 1. J. Virol. 61 (1987) 3726-3732
136. Ott M., Emiliani S., Van Lint C., Herbein G., Lovett J., Chirmule N., McCloskey T., Pahwa S., and Verdin E. Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science 275 (1997) 1481-1485
137. Palu G., Benetti L., and Calistri A. Molecular basis of the interactions between herpes simplex viruses and HIV-1. Herpes 8 (2001) 50-55
138. Parker S.F., Felzien L.K., Perkins N.D., Imperiale M.J., and Nabel G.J. Distinct domains of adenovirus E1A interact with specific cellular factors to differentially modulate human immunodeficiency virus transcription. J. Virol. 71 (1997) 2004-2012
139. Penn I. Kaposi's sarcoma in organ transplant recipients: report of 20 cases. Transplantation 27 (1979) 87-90
140. Peruzzi F. The multiple functions of HIV-1 tat: proliferation versus apoptosis. Front. Biosci. 11 (2006) 708-717
141. Pessler F., and Cron R.Q. Reciprocal regulation of the nuclear factor of activated T cells and HIV-1. Genes Immun. 5 (2004) 158-167
142. Pietropaolo V., Fioriti D., Simeone P., Vedetta M., Di Taranto C., Arancio A., Orsi N., and Degener A.M. Detection and sequence analysis of human polyomaviruses DNA from autoptic samples of HIV-1 positive and negative subjects. Int. J. Immunopathol. Pharmacol. 16 (2003) 269-276
143. Polk B.F., Fox R., Brookmeyer R., Kanchaaraksa S., Kaslow R., Visscher B., Rinaldo C., and Phair J. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N. Engl. J. Med. 316 (1987) 61-66
144. Popik W., and Pitha P.M. The presence of Tat protein or tumor necrosis factor alpha critical for herpes simplex virus type 1-induced expression of human immunodeficiency virus type 1. J. Virol. 68 (1994) 1324-1333
145. Pumfery A., Deng L., Maddukuri A., de la Fuente C., Li H., Wade J.D., Lambert P., Kumar A., and Kashanchi F. Chromatin remodeling and modification during HIV-1 Tat-activated transcription. Curr. HIV Res. 1 (2003) 343-362
146. Rabkin C.S., Janz S., Lash A., et al. Monoclonal origin or multicentric Kaposi's sarcoma lesions. NEJM 336 (1997) 988-993
147. Rappaport J., Joseph J., Croul S., Alexander G., Del Valle L., Amini S., and Khalili K. Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein Tat. J. Leukocyte Biol. 65 (1999) 458-465
148. Rautonen N., Rautonen J., Martin N.L., and Wara D.W. HIV-1 Tat induces cytokine synthesis by uninfected mononuclear cells. AIDS 8 (1994) 1504-1506
149. Reinhart T.A. Chemokine induction by HIV-1: recruitment to the cause. Trends Immunol. 24 (2003) 351-353
150. Rice A.P., and Mathews M.B. Trans-activation of the human immunodeficiency virus long terminal repeat sequences, expressed in an adenovirus vector, by the adenovirus E1A 13S protein. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 4200-4204
151. Richman D.D. HIV chemotherapy. Nature 410 (2001) 995-1001
152. Roels P. Ocular manifestations of AIDS: new considerations for patients using highly active anti-retroviral therapy (HAART). Optometry 75 (2004) 624-628
153. Rosenblatt J.D., Miles S., Gasson J.C., and Prager D. Transactivation of cellular genes by human retroviruses. Curr. Top. Microbiol. Immunol. 193 (1995) 25-49
154. Safak M., Gallia G.L., and Khalili K. A 23-bp sequence element from human neurotropic JC virus is responsive to NF-kappa B subunits. Virology 15 (1999) 178-189
155. Sarnow P., Ho Y.S., Williams J., and Levine A.J. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 28 (1982) 387-394
156. Sawaya B.E., Khalili K., Mercer W.E., Denisova L., and Amini S. Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription. J. Biol. Chem. 273 (1998) 20052-20057
157. Sawaya B.E., Khalili K., Gordon J., Taube R., and Amini S. Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome. J. Biol. Chem. 275 (2000) 35209-35214
158. Scala G., Quinto I., Ruocco M.R., Mallardo M., Ambrosino C., Squiter B., Tassone P., and Venuta S. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 67 (1993) 2853-2861
159. Scala G., Ruocco M.R., Ambrosino C., Mallardo M., Giordano V., Baldassarre F., Dragonetti E., Quinto I., and Venuta S. The expression of the interleukin r gene is induced by the human immunodeficiency virus TAT protein. J. Exp. Med. 179 (1994) 961-971
160. Schacker T. The role of HSV in the transmission and progression of HIV. Herpes 8 (2001) 46-49
161. Schafer S.L., Vlach J., and Pitha P.M. Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site. J. Virol. 70 (1996) 6937-6946
162. Schulz T.F., Boshoff C.H., and Weiss R.A. HIV infection and neoplasia. Lancet 348 (1996) 587-591
163. Seelamgari A., Maddukuri A., Berro R., de la Fuente C., Kehn K., Deng L., Dadgar S., Bottazzi M.E., Ghedin E., Pumfery A., and Kashanchi F. Role of viral regulatory and accessory proteins in HIV-1 replication. Front Biosci. 9 (2004) 2388-2413
164. Selliah N., and Finkel T.H. Biochemical mechanisms of HIV induced T cell apoptosis. Cell Death Differ. 8 (2001) 127-136
165. Sharma V., Walper D., and Deckert R. Modulation of macrophage inflammatory protein-1alpha and its receptors in human B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma. Biochem. Biophys. Res. Commun. 235 (1997) 576-581
166. Sieczkowski L., Chandran B., and Wood C. The human immunodeficiency virus tat gene enhances replication of human herpesvirus-6. Virology 211 (1995) 544-553
167. Skolnik P.R., Kolsoff B.R., and Hirsch M.S. Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. J. Infect. Dis. 157 (1988) 508-514
168. Smith R.D., Galla J.H., Skahan K., Anderson P., Linnemann C.C., Ault G.S., Ryschkewitch C.F., and Stoner G.L. Tubulointerstitial nephritis due to a mutant polyomavirus BK virus strain, BKV(Cin), causing end-stage renal disease. J. Clin. Microbiol. 36 (1998) 1660-1665
169. Sun Q., Zachariah S., and Chaudhary P.M. The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation. J. Biol. Chem. 278 (2003) 52437-52445
170. Sweet T., Sawaya B.E., Khalili K., and Amini S. Interplay between NFBP and NF-kappaB modulates tat activation of the LTR. J. Cell. Physiol. 204 (2005) 375-380
171. Tada H., Rappaport J., Lashgari M., Amini S., Wong-Staal F., and Khalili K. Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 3479-3483
172. Taylor J.P., Pomerantz R.J., Oakes J.W., Khalili K., and Amini S. A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat. Oncogene 10 (1995) 395-400
173. Theise N.D., Rotterdam H., and Deiterich D. Cytomegalovirus esophagitis in AIDS: diagnosis by endoscopic biopsy. Am. J. Gastroenterol. 86 (1991) 1123-1126
174. Toschi E., Barillari G., Sgadari C., Bacigalupo I., Ceresto A., Carlei D., Palladino C., Zeitz C., Leone P., Sturtzl M., Butto S., Cafaro A., Monini P., and Ensoli B. Activation of matrix-metalloproteinase-2 and membrane-type-1-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor. Mol. Biol. Cell 12 (2001) 2934-2946
175. Toy E.P., Rodriguez-Rodriguez L., McCance D., Ludlow J., and Planelles V. Induction of cell-cycle arrest in cervical cancer cells by the human immunodeficiency virus type 1 viral protein R. Obstet. Gynecol. 95 (2000) 141-146
176. Vallbracht A., Lohler J., Gossmann J., Gluck T., Peterson D., Gerth H.J., Gencic M., and Dorries K. Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am. J. Pathol. 143 (1993) 29-39
177. Varthakavi V., Smith R.M., Deng H., Sun R., and Spearman P. Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta. Virology 297 (2002) 270-280
178. Vogel J., Hinrichs S.H., Reynolds R.K., Luciw P.A., and Jay G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 335 (1988) 606-611
179. Wang J., Jones C., Norcross M., Bohlein E., and Razzaque A. Identification and characterization of a human herpesvirus-6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner. J. Virol. 68 (1994) 1706-1713
180. Wang L., Mukherjee S., Jia F., Narayan O., and Zhao L.J. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J. Biol. Chem. 270 (1995) 25564-25569
181. Webster A. Cytomegalovirus as a possible cofactor in HIV disease progression. J. Acquired Immune Defic. Syndr. 4 S1 (1991) S47-S52
182. Weiss R.A., Whitby D., Talbot S., Kellam P., and Boshoff C. Human herpesvirus type 8 and Kaposi's sarcoma. J. Natl. Cancer Inst. Monogr. 23 (1998) 51-54
183. White M.K., and Khalili K. Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. Virology 324 (2004) 1-16
184. White M.K., and Khalili K. Signaling pathways and polyomavirus oncoproteins: importance in malignant transformation. Gene Ther. Mol. Biol. 8 (2004) 19-30
185. White M.K., and Khalili K. Expression of JC virus regulatory proteins in human cancer: potential mechanisms for tumourigenesis. Eur. J. Cancer 41 (2005) 2537-2548
186. Whyte P., Buchkovich K.J., Horowitz J.M., Friend S.H., Raybuck M., Weinberg R.A., and Harlow E. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334 (1988) 124-129
187. Wilson R.J. Cytomegalovirus retinitis in AIDS. J. Am. Optom. Assoc. 63 (1992) 49-58
188. Wortman M.J., Krachmarov C.P., Kim J.H., Gordon R.G., Chepenik L.G., Brady J.N., Gallia G.L., Khalili K., and Johnson E.M. Interaction of HIV-1 Tat with Puralpha in nuclei of human glial cells: characterization of RNA-mediated protein-protein binding. J. Cell. Biochem. 77 (2000) 65-74
189. Wyen C., Hoffman C., Schmeier N., Wohrmann A., Qurishi N., Rockstroh J., Esser S., Reike A., Ross B., Lorenzen T., Schmitz K., Stenzel W., Salzberger B., and Fatkenheuer G. Progressive multifocal leukoencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death. J. Acq. Imm. Def. Synd. 37 (2004) 1263-1268
190. Yen-Moore A., Hudnall S.D., Rady P.L., Wagner R.F., Moore T.O., Memar O., Hughes T.K., and Tyring S.K. Differential expression of the HHV-8 vGCR cellular homolog gene in AIDS-associated and classic Kaposi's sarcoma: potential role of HIV-1 Tat. Virology 267 (2000) 247-251
191. Zauli G., and Gibellini D. The human immunodeficiency virus type-1 (HIV-1) Tat protein and Bcl-2 gene expression. Leuk. Lymphoma 23 (1996) 551-560
192. Zauli G., Davis B.R., Re M.C., Visani G., Furlini G., and La Placa M. Tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 80 (1992) 3036-3043
193. Zhang R.D., Guan M., Park Y., Tawadros R., Yang J.Y., Gold B., Wu B., and Henderson H.H. Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines. AIDS Res. Hum. Retroviruses 13 (1997) 161-171
194. Zimmermann K., Dobrovnik M., Ballaun C., Bevec D., Hauber J., and Bohnlein E. Trans-activation of the HIV-1 LTR by the HIV-1 Tat and HTLV-I Tax proteins is mediated by different cis-acting sequences. Virology 182 (1991) 874-878